查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530408

癌症治療設施市場規模、佔有率、趨勢分析報告：按治療、癌症類型、提供者、地區和細分市場預測，2024-2030 年

Cancer Treatment Facilities Market Size, Share, & Trends Analysis Report By Treatment (Cancer Surgery, Chemotherapy), By Cancer Type (Blood Cancer, Breast Cancer), By Provider, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

癌症治療設施市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球癌症治療設施市場規模預計將達到787.1億美元，預測期內複合年成長率為7.75%。

市場成長的主要驅動力包括增加患者援助計劃、政府提高癌症意識的措施以及對個人化醫療的需求不斷增加。

全球女性乳癌等腫瘤的盛行率不斷上升，使得乳癌成為醫療保健提供者的重要專業和投資目標。對先進診斷技術、個人化醫療和客製化治療方法的需求預計將改善患者的治療結果和生存率，並在預測期內推動該行業的成長。例如，2024 年 1 月，米高梅醫療保健公司開設了 B 診所，為患者提供針對所有類型乳房健康問題的全面、先進的治療，從良性腫塊和囊腫到腫瘤和重組。

此外，免疫療法最近已成為某些癌症治療的重要組成部分。免疫療法是一種日益先進的治療方法，可以透過針對癌症特異性標靶來增強免疫系統對抗癌症的能力。因此，服務供應商正在加強其策略性舉措，以增加其在市場上的影響力，預計這將成為未來幾年成長的驅動力。 2023 年 1 月，BioNTech SE 將與英國政府合作，到年終為多達 10,000 名患者提供工程化 mRNA 免疫療法的臨床試驗。我們也專注於提供感染疾病疫苗並進行投資以擴大我們在英國市場的足跡。

此外，一些行業參與者正在推出新服務以提高滲透率。例如，2024 年 3 月，坦帕總醫院在坦帕主院成立了 TGH 癌症研究所一期癌症研究中心。這一期癌症研究中心的目的是為癌症患者提供前沿研究與富有同情心的綜合護理相結合的機會。

癌症治療設施市場報告亮點：

  • 在治療方面，癌症手術細分市場佔據主導地位，2023年銷售佔有率為34.12%。機器人手術技術的發展和日益普及對該領域的發展產生了重大影響。然而，化療服務在預測期內成長最快。
  • 根據癌症類型，血癌細分市場在 2023 年佔據最大的收益佔有率。這一成長是由於全球主要企業擴大參與血癌治療的研發而推動的。
  • 按提供者分類，由於先進的腫瘤診斷和治療能力，醫院部門在 2023 年佔據了最大的收益佔有率。
  • 由於癌症發病率上升、個人化醫療需求增加以及醫療基礎設施不斷發展等因素，亞太地區在 2023 年佔據市場主導地位。
  • 2024年5月，HCG（Healthcare Global Enterprise）在北班加羅爾開設了新的癌症治療中心，總合增加了125個病床。這些地理位置優越的設施提供全方位的先進癌症護理，從診斷到個人化治療計劃。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 波特五力分析
    • PESTLE分析

第 4 章 癌症治療設施市場：按治療分類的估計和趨勢分析

  • 2023 年和 2030 年按治療方法市場佔有率
  • 治療細分儀表板
  • 2018 年至 2030 年市場規模以及按處理和趨勢分析進行的預測
  • 骨髓移植
  • 化療
  • 放射治療
  • 荷爾蒙療法
  • 免疫療法
  • 癌症手術

第5章癌症治療設施市場：按癌症類型的估計和趨勢分析

  • 2023 年和 2030 年按癌症類型分類的市場佔有率佔有率
  • 按癌症類型細分儀表板
  • 2018-2030年按癌症類型分類的市場規模及預測與趨勢分析
  • 血癌
  • 乳癌
  • 攝護腺癌
  • 消化道癌症
  • 婦科癌症
  • 呼吸道/肺癌
  • 其他癌症類型

第6章癌症治療設施市場：提供者的估計和趨勢分析

  • 2023 年和 2030 年按提供者分類的市場佔有率
  • 按提供者細分儀表板
  • 2018-2030 年市場規模、提供者預測與趨勢分析
  • 癌症中心
  • 醫院

第7章癌症治療設施市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 2018-2030 年北美癌症治療設施市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲癌症治療設施市場估計與預測
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區癌症治療設施市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲癌症治療設施市場估計與預測，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東和非洲癌症治療設施市場估計和預測，2018-2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/名單
    • Compass Oncology
    • American Oncology Institute
    • Mayo Foundation for Medical Education and Research（MFMER）
    • HCA International Limited
    • The Royal Marsden
    • National Cancer Instituteat the National Institutes of Health
    • Apollo Hospitals Enterprise Ltd.
    • Kokilaben Dhirubhai Ambani Hospital
    • HEALTHCARE GLOBAL ENTERPRISES LIMITED
    • The Johns Hopkins Hospital
    • Tata Memorial Centre.
Product Code: GVR-4-68040-374-3

Cancer Treatment Facilities Market Growth & Trends:

The global cancer treatment facilities market size is anticipated to reach USD 78.71 billion by 2030 and is anticipated to grow at a CAGR of 7.75% over the forecast period, according to a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.

The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected to drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B to support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts to tumors and reconstruction.

Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due to its ability to enhance the immune system's ability to fight cancer by directing it toward cancer-specific targets; this leads to growing strategic initiatives by the service providers to grow its presence in the market, which is expected to drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government to provide clinical trials for modified mRNA immunotherapies for up to 10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment to increase its footprint in the UK market.

Furthermore, several industry players are launching new services to improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is to provide cancer patients with access to leading-edge research studies integrated with compassionate and comprehensive care.

Cancer Treatment Facilities Market Report Highlights:

  • In terms of treatment, the cancer surgery segment dominated the market with a revenue share of 34.12% in 2023. The development and increasing adoption of robotic surgery techniques is having a significant impact on the growth of the segment. However, chemotherapy services are the fastest-growing segment during the forecast period.
  • Based on the cancer type, the blood cancer segment accounted for the maximum revenue share in 2023. This growth is attributed to the increasing involvement of key companies in the R&D of blood cancer treatments globally.
  • Based on provider, the hospital segment accounted for the maximum revenue share in 2023 due to its advanced diagnostic and treatment capabilities in oncology departments.
  • Asia Pacific dominated the market in 2023 due to factors such as the growing cancer incidence, increasing demand for personalized care, and the rise in the development of healthcare infrastructure.
  • In May 2024, HCG (Healthcare Global Enterprises) opened new cancer care centers in North Bengaluru, adding a total of 125 beds. These strategically positioned facilities will provide a complete range of advanced cancer treatments, from diagnosis to personalized treatment plans.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Cancer Type
    • 1.2.3. Provider
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Volume Price Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of cancers
      • 3.2.1.2. Technology advancement
      • 3.2.1.3. Rising medical tourism
      • 3.2.1.4. Growing government investment in cancer treatment facility
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High initial investment cost to setup cancer treatment facility
      • 3.2.2.2. Stringent regulations for cancer treatment facility setup
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Cancer Treatment Facilities Market: Treatment Estimates & Trend Analysis

  • 4.1. Treatment Market Share, 2023 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Bone Marrow Transplantation
    • 4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Chemotherapy
    • 4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Radiation Therapy
    • 4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hormone Therapy
    • 4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Immunotherapy
    • 4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.9. Cancer Surgery
    • 4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cancer Treatment Facilities Market: Cancer Type Estimates & Trend Analysis

  • 5.1. Cancer Type Market Share, 2023 & 2030
  • 5.2. Cancer Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
  • 5.4. Blood Cancer
    • 5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Breast Cancer
    • 5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Prostate Cancer
    • 5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Gastrointestinal Cancer
    • 5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.8. Gynecologic Cancer
    • 5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.9. Respiratory/Lung Cancer
    • 5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.10. Other Cancer Types
    • 5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cancer Treatment Facilities Market: Provider Estimates & Trend Analysis

  • 6.1. Provider Market Share, 2023 & 2030
  • 6.2. Provider Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
  • 6.4. Cancer Centers
    • 6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cancer Treatment Facilities Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. UK
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamic
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive insights
      • 7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamic
      • 7.5.9.2. Regulatory framework
      • 7.5.9.3. Competitive insights
      • 7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamic
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive insights
      • 7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamic
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive insights
      • 7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key country dynamic
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive insights
      • 7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamic
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive insights
      • 7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamic
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive insights
      • 7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamic
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive insights
      • 7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamic
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive insights
      • 7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamic
      • 7.8.5.2. Regulatory framework
      • 7.8.5.3. Competitive insights
      • 7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Compass Oncology
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Service benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. American Oncology Institute
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Service benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Service benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. HCA International Limited
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Service benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. The Royal Marsden
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Service benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. National Cancer Instituteat the National Institutes of Health
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Service benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Apollo Hospitals Enterprise Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Service benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Kokilaben Dhirubhai Ambani Hospital
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Service benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Service benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. The Johns Hopkins Hospital
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Service benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Tata Memorial Centre.
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Service benchmarking
      • 8.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 4 Global cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 5 Global cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 6 Global cancer treatment facilities market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 9 North America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 10 North America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 11 U.S. cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 U.S. cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 13 U.S. cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 14 Canada cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 15 Canada cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 16 Canada cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 17 Mexico cancer treatment facilities market, by teatment, 2018 - 2030 (USD Million)
  • Table 18 Mexico cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 19 Mexico cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 20 Europe cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Europe cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 22 Europe cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 23 UK cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 24 UK cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 25 UK cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 26 Germany cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Germany cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 28 Germany cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 29 France cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 30 France cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 31 France cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 32 Italy cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Italy cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 34 Italy cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 35 Spain cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Spain cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 37 Spain cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 38 Norway cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 39 Norway cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 40 Norway cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 41 Sweden cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 Sweden cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 43 Sweden cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 44 Denmark cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 45 Denmark cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 46 Denmark cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 51 Japan cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 52 Japan cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 53 Japan cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 54 China cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 China cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 56 China cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 57 India cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 India cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 59 India cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 60 Australia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 61 Australia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 62 Australia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 63 South Korea cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 South Korea cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 65 South Korea cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 66 Thailand cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 67 Thailand cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 68 Thailand cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 69 Latin America cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 71 Latin America cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 72 Latin America cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 73 Brazil cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 74 Brazil cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 75 Brazil cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 76 Argentina cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 77 Argentina cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 78 Argentina cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa cancer treatment facilities market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 83 South Africa cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 84 South Africa cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 85 South Africa cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 89 UAE cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 90 UAE cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 91 UAE cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)
  • Table 92 Kuwait cancer treatment facilities market, by treatment, 2018 - 2030 (USD Million)
  • Table 93 Kuwait cancer treatment facilities market, by cancer type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait cancer treatment facilities market, by provider, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market segmentation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market trends & outlook
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 PESTLE analysis
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Cancer treatment facilities market: Treatment outlook and key takeaways
  • Fig. 17 Cancer treatment facilities market: Treatment movement analysis
  • Fig. 18 Bone marrow transplantation market revenue, 2018 - 2030 (USD Million)
  • Fig. 19 Chemotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 20 Radiation therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 21 Hormone therapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 22 Immunotherapy market revenue, 2018 - 2030 (USD Million)
  • Fig. 23 Cancer surgery market revenue, 2018 - 2030 (USD Million)
  • Fig. 24 Cancer treatment facilities market: Cancer type outlook and key takeaways
  • Fig. 25 Cancer treatment facilities market: Cancer type movement analysis
  • Fig. 26 Blood cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 27 Breast cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 28 Prostate cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 30 Gynecologic cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 31 Respiratory/Lung cancer market revenue, 2018 - 2030 (USD Million)
  • Fig. 32 Other cancer types market revenue, 2018 - 2030 (USD Million)
  • Fig. 33 Cancer treatment facilities market: Provider outlook and key takeaways
  • Fig. 34 Cancer treatment facilities market: Provider movement analysis
  • Fig. 35 Cancer centers market revenue, 2018 - 2030 (USD Million)
  • Fig. 36 Hospitals market revenue, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional outlook, 2023 & 2030
  • Fig. 39 Cancer treatment facilities market: Region movement analysis
  • Fig. 40 North America cancer treatment facilities market, 2018-2030, (USD Million)
  • Fig. 41 US key country dynamics
  • Fig. 42 US cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamic
  • Fig. 49 UK cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamic
  • Fig. 51 Germany cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamic
  • Fig. 53 France cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamic
  • Fig. 55 Italy cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamic
  • Fig. 57 Spain cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamic
  • Fig. 59 Denmark cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamic
  • Fig. 61 Sweden cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamic
  • Fig. 63 Norway cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 65 China key country dynamic
  • Fig. 66 China cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan key country dynamic
  • Fig. 68 Japan cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamic
  • Fig. 70 India cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea key country dynamic
  • Fig. 72 South Korea cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia key country dynamic
  • Fig. 74 Australia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand key country dynamic
  • Fig. 76 Thailand cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamic
  • Fig. 79 Brazil cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamic
  • Fig. 81 Argentina cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 82 MEA cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamic
  • Fig. 84 South Africa cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamic
  • Fig. 86 Saudi Arabia cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamic
  • Fig. 88 UAE cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamic
  • Fig. 90 Kuwait cancer treatment facilities market, 2018 - 2030 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Strategy mapping
  • Fig. 93 Company market position analysis